MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D8F861.F1A72990"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D8F861.F1A72990
Content-Location: file:///C:/680CD4E2/UA197350101_83EB.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA197350101_83EB.files/filelist.xml">
<link rel=3DPreview href=3D"UA197350101_83EB.files/preview.wmf">
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Олехнович Ірина Леонідівна</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>6</o:TotalTime>
  <o:Created>2022-11-14T17:47:00Z</o:Created>
  <o:LastSaved>2022-11-14T17:47:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>1095</o:Words>
  <o:Characters>6245</o:Characters>
  <o:Company>SPecialiST RePack</o:Company>
  <o:Lines>52</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7326</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DthemeData href=3D"UA197350101_83EB.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA197350101_83EB.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750139 0 0 415 0;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;
	mso-font-charset:204;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:Calibri;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
h2
	{mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Заголовок 2 Знак";
	mso-style-next:Обычный;
	margin-top:10.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:13.0pt;
	font-family:"Calibri Light","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	color:#5B9BD5;
	mso-ansi-language:UK;
	mso-fareast-language:EN-US;}
span.2
	{mso-style-name:"Заголовок 2 Знак";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Заголовок 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri Light","sans-serif";
	mso-ascii-font-family:"Calibri Light";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Calibri Light";
	mso-bidi-font-family:"Times New Roman";
	color:#5B9BD5;
	mso-ansi-language:UK;
	font-weight:bold;}
p.Iauiue, li.Iauiue, div.Iauiue
	{mso-style-name:Iau?iue;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:none;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Bookman Old Style","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:UK;
	mso-fareast-language:UK;}
span.spelle
	{mso-style-name:spelle;
	mso-style-unhide:no;
	mso-style-parent:"";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:2.0cm 42.5pt 2.0cm 3.0cm;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-bidi-font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:36.0pt'>

<div class=3DWordSection1>

<h2 style=3D'text-align:justify'><span lang=3DUK style=3D'font-size:12.0pt;
font-family:"Times New Roman","serif";color:#C00000'><span
style=3D'mso-spacerun:yes'>                                                =
                  
</span></span><span lang=3DUK style=3D'font-size:12.0pt;font-family:"Times =
New Roman","serif";
color:black'>ІНСТРУКЦІЯ<o:p></o:p></span></h2>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><span
style=3D'mso-spacerun:yes'>                                      </span>для
медичного застосування лікарського засобу<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p>&nbsp;</o:p></span></b=
></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;text-transform:u=
ppercase'>диметилсульфоксид</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;color:black'> <o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>(</=
span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;text-transform:uppercase'>Dimethylsulfoxide</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'mso-bidi-fon=
t-size:
12.0pt;color:black'>)<span style=3D'mso-bidi-font-weight:bold'><o:p></o:p><=
/span></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:#C00000'><o:p>&nbsp;</o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Скл=
ад:</span></i></b><i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'>діюча речовина: </span></i>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>диметилсульфоксид;<span
style=3D'mso-spacerun:yes'>           </span><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'>1 г гелю містить </span><span lang=3DUK style=3D'mso-bi=
di-font-size:
12.0pt'>диметилсульфоксиду<span style=3D'mso-bidi-font-style:italic'> </spa=
n></span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>–</span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt'>
500 мг<span style=3D'color:black'>;<i style=3D'mso-bidi-font-style:normal'>=
<o:p></o:p></i></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>доп=
оміжні
речовини:</span></i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;colo=
r:#C00000'>
</span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>карбомер, т<span
style=3D'letter-spacing:-.25pt'>риетаноламін</span>, левоментол, вода очище=
на.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black;mso-=
bidi-font-style:
italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black;mso-=
bidi-font-style:
italic'>Лікарська форма. </span></b><span lang=3DUK style=3D'mso-bidi-font-=
size:
12.0pt;color:black'>Гель для зовнішнього застосування.<i><o:p></o:p></i></s=
pan></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'>Основні фізико-хімічні
властивості:</span></i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
color:black'> </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>бе=
збарвний
або жовтуватий гель з характерним запахом. Допускається наявність опалесцен=
ції
і бульбашок повітря.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:#C00000;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan;
tab-stops:40.85pt 492.6pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:"Times New Roman",=
"serif";
color:black;mso-bidi-font-style:italic'>Фармакотерапевтична група. </span><=
/b><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:"Times New Roman",=
"serif"'>Засоби
для місцевого застосування при суглобовому та м’язовому болю. </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;font-family:"Times New Roman",=
"serif";
mso-fareast-language:RU'>Код АТХ </span><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
12.0pt;font-family:"Times New Roman","serif"'>M02A X03</span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;font-family:"Times New Roman","serif";
mso-fareast-language:RU'>.</span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
font-family:"Times New Roman","serif"'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:#C00000'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>Фармакологічні властивості.</span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:black'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Фар=
макодинаміка.<span
style=3D'mso-spacerun:yes'>                             </span></span></i><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Протизапальний лікарський засіб для зовнішнього
застосування, інактивує гідроксильні радикали, покращує перебіг метаболічних
процесів у вогнищі запалення. Чинить місцевоанестезуючу, аналгезуючу та
антимікробну дію; має помірну фібринолітичну активність. Проникає через шкі=
ру,
слизові оболонки, оболонку мікробних клітин (підвищує їх чутливість до
антибіотиків) та інші біологічні мембрани, підвищує їх проникність для
лікарських засобів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Фар=
макокінетика.</span></i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Після нанесення лікарського засобу диметилсульфокс=
ид
виявляється в сироватці крові через 8–15 хвилин, максимальний вміст
відзначається через 2–8 годин. Як правило, через 30–36 годин диметилсульфок=
сид
в сироватці крові вже не виявляється.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Диметилсульфоксид не акумулюється. При місцевому
застосуванні диметилсульфоксид проникає в суглобову порожнину, в крові і тк=
анинах
зв’язується з білками.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Диметилсульфоксид виводиться з організму нирками у
незміненому вигляді і у вигляді продуктів окислення — диметилсульфону і
диметилсульфату; крім того, у вигляді відновленого продукту (диметилсульфід=
у)
виділяється з повітрям, що видихається.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Клі=
нічні
характеристики.<i><o:p></o:p></i></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>=
Показання.</span></i></b><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Застосовувати у <=
span
class=3Dspelle>складі</span> <span class=3Dspelle>комплексної</span> <span
class=3Dspelle>терапії</span> <span class=3Dspelle>ревматоїдного</span> арт=
риту,
хвороби <span class=3Dspelle>Бехтерева</span>, <span class=3Dspelle>деформу=
ючого</span>
<span class=3Dspelle>остеоартрозу</span> (за <span class=3Dspelle>наявності=
</span> <span
class=3Dspelle>ураження</span> <span class=3Dspelle>періартикулярних</span>
тканин); при <span class=3Dspelle>артропатії</span>, <span class=3Dspelle>р=
озтягненні</span>
<span class=3Dspelle>сухожиль</span> внаслідок <span class=3Dspelle>удару</=
span>,
при <span class=3Dspelle>травматичних</span> <span class=3Dspelle>інфільтра=
тах</span>,
<span class=3Dspelle>гострих</span> та <span class=3Dspelle>хронічних</span=
> <span
class=3Dspelle>остеомієлітах</span>, <span class=3Dspelle>стрептодермії</sp=
an>, <span
class=3Dspelle>гнійних</span> ранах, <span class=3Dspelle>абсцесах</span>.<=
/span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
color:black;mso-fareast-language:RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><b
style=3D'mso-bidi-font-weight:normal'><i><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:black'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><b
style=3D'mso-bidi-font-weight:normal'><i><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:black'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><b
style=3D'mso-bidi-font-weight:normal'><i><span lang=3DUK style=3D'mso-bidi-=
font-size:
12.0pt;color:black'>Протипоказання.</span></i></b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Підвищена чутливість до диметилсульфоксиду або інш=
их
компонентів лікарського засобу. </span><span lang=3DUK style=3D'mso-bidi-fo=
nt-size:
12.0pt'>Серцево-судинна недостатність, виражений атеросклероз, стенокардія,
порушення функції нирок або печінки, інсульт, інфаркт міокарда, коматозні
стани, глаукома, катаракта.</span><span lang=3DUK style=3D'mso-bidi-font-si=
ze:12.0pt;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'> <o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Сумісне застосування з лікарс=
ькими
засобами, що містять суліндак. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Вагітність, період годування груддю, дитячий вік д=
о 12
років.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:=
p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Вза=
ємодія з
іншими лікарськими засобами та інші види вза</span></i></b><b style=3D'mso-=
bidi-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>ємодій.</span></i></b><span lang=3DUK style=3D'mso-bidi=
-font-size:
12.0pt;color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";color:black;mso-fareast-la=
nguage:
RU'>Лікарський засіб збільшує всмоктування і підсилює дію етанолу (алкоголь=

гальмує виведення препарату), інсуліну (при тривалому застосуванні лікарськ=
ого
засобу необхідно контролювати вміст глюкози в плазмі крові), кислоти
ацетилсаліцилової, бутадіону; препаратів дигіталісу, хінідину, нітрогліцери=
ну,
антибіотиків (стрептоміцину, мономіцину), хлорамфеніколу, рифампіцину,
гризеофульвіну, підвищує чутливість організму до засобів для наркозу. </spa=
n><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Слід враховувати посилення ди=
метилсульфоксидом
як специфічної активності, так і токсичності лікарських засобів. <o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt'>Диметилсульфоксид</span><span lang=3DUK style=3D'mso-bidi-font-size=
:12.0pt;
mso-fareast-font-family:"Times New Roman";color:black;mso-fareast-language:
RU'> не можна застосовувати із суліндаком (нестероїдний протизапальний засі=
б)
через можливість виникнення тяжких токсичних реакцій (периферичної нейропат=
ії).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";color:black;mso-fareast-language:
RU'>Сумісний з гепарином, </span><span lang=3DUK style=3D'mso-bidi-font-siz=
e:12.0pt;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>антибакт=
еріальними
засобами, <span style=3D'color:black'>нестероїдними протизапальними засобам=
и.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
color:black;mso-fareast-language:RU'>У разі прийому будь-яких інших лікарсь=
ких
засобів слід обов’язково проконсультуватися з лікарем щодо можливості
застосування лікарського засобу </span></i><i style=3D'mso-bidi-font-style:=
normal'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Диметилсульфоксид</span></i><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;mso-fareast-font-family:"Times New Roman";color:black;mso-fareast-la=
nguage:
RU'>.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>Особливості застосування.</span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;color:black;mso-bidi-font-weight:bold'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Не нанос=
ити
на ушкоджену шкіру та шкіру з проявами алергії. Не наносити на шкіру обличч=
я. Деякі
пацієнти відчувають запах часнику у вдихуваному повітрі в період застосуван=
ня
лікарського засобу.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>З огляду на можливість індивідуальної непереносимо=
сті
лікарського засобу перед застосуванням необхідно проводити пробу на перенос=
имість.
Для цього гель тонким шаром наносять на шкіру ліктьового згину; поява гіпер=
емії
і вираженого свербежу свідчить про гіперчутливість.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>При виникненні в ході лікування алергічних реакцій
застосування лікарського засобу припиняють, призначають блокатори Н<sub>1</=
sub>-гістамінових
рецепторів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Пацієнти
літнього віку можуть застосовувати препарат після попередньої консультації з
лікарем. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Не допус=
кати
потрапляння гелю на слизові оболонки та в очі. При випадковому потраплянні
препарату в очі їх слід негайно промити проточною водою.<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Н=
анесення
диметилсульфоксиду може спричинити розвиток фотосенсибілізації. У зв’язку з=
 цим
при застосуванні гелю </span><span lang=3DUK style=3D'mso-bidi-font-size:12=
.0pt'>Диметилсульфоксид<span
style=3D'color:black'> </span></span><span lang=3DUK style=3D'mso-bidi-font=
-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>с=
лід
утримуватися від засмагання та відвідування солярію. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU;mso-bidi-font-weight:bold'>Застосування у період
вагітності або годування груддю.<b><o:p></o:p></b></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>П=
овідомлялося,
про потенційний тератогенний вплив диметилсульфоксиду у тварин.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Д=
освіду
застосування диметилсульфоксиду вагітним жінкам на цей час недостатньо, том=
у застосування
лікарського засобу </span><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t'>Диметилсульфоксид</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'> у період вагітності протипоказане.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Д=
иметилсульфоксид
проникає у грудне молоко, тому застосування лікарського засобу</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'> Диметилсульфоксид</span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'> у період годування груддю протипоказане.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span>=
</i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU;mso-bidi-font-weight:bold'>Здатність впливати на
швидкість реакції при керуванні автотранспортом або іншими механізмами.<o:p=
></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Лікарськ=
ий
засіб слід застосовувати з обережністю з огляду на можливий вплив на центра=
льну
нервову систему, зокрема через імовірність виникнення запаморочення.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:#C00000;background:aqua'><o:p>&nbs=
p;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:=
p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Спо=
сіб
застосування та дози.</span></i></b><span lang=3DUK style=3D'mso-bidi-font-=
size:
12.0pt;color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:45.8pt 91.6pt 13=
7.4pt 183.2pt 229.0pt 274.8pt 320.6pt 366.4pt 412.2pt 458.0pt 503.8pt 549.6=
pt 595.4pt 641.2pt 687.0pt 732.8pt'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>Гель наносити на уражену ділянку тонким шаром, зле=
гка
втираючи, 1–2 рази на добу. Тривалість лікування 10–14 днів. Повторний курс
рекомендовано проводити не менше ніж через 10 днів.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black;background:aqua'><o:p>&nbsp;=
</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black;mso-bidi-font-weight:bold'>Д=
іти.</span></i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'>Не призначають дітям до 12 років.<b><o:p></o:p></b></sp=
an></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p>&nbsp;</o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>Передозування.</span></i></b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font=
-family:
"Times New Roman";mso-fareast-language:RU'>Симптоми: </span></i><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>можливе </span><span lang=3DUK style=3D'mso-bidi-f=
ont-size:
12.0pt'>виникнення алергічних реакцій (кропив’янка, набряк) та </span><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'>посилення побічних ефектів лікарського засобу, </s=
pan><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>що потребує припинення
застосування.<span style=3D'mso-spacerun:yes'>  </span><o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font=
-family:
"Times New Roman";mso-fareast-language:RU'>Лікування: </span></i><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>симптоматичне.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>Побічні реакції.</span></i></b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DUK style=3D'mso-bidi-font-size:12.0p=
t;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>Диметилс=
ульфоксид
зазвичай добре переноситься, але у деяких хворих можливі: <o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>З боку імунної системи:</span></i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'> алергічні реакції, включаючи дерматити, шкірний
висип, ангіоневротичний набряк, свербіж, печіння, гіперемію шкіри, еритему,
сухість шкіри.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>З боку шлунково-кишкового тракту:</span></i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'> нудота, блювання, діарея.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>З боку центральної і периферичної нервової системи=
:</span></i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
mso-fareast-language:RU'> головний біль, запаморочення, безсоння, адинамія.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'>З боку органів дихання:</span></i><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
mso-fareast-language:RU'> бронхоспазм.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font=
-family:
"Times New Roman";color:black;mso-fareast-language:RU'>З боку шкіри: </span=
></i><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times=
 New Roman";
color:black;mso-fareast-language:RU'>реакції фоточутливості.<i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span class=3Dspelle><spa=
n lang=3DUK
style=3D'mso-bidi-font-size:12.0pt'>Повідомлення</span></span><span lang=3D=
UK
style=3D'mso-bidi-font-size:12.0pt'> про <span class=3Dspelle>побічні</span=
> <span
class=3Dspelle>реакції</span> <span class=3Dspelle>після</span> <span class=
=3Dspelle>реєстрації</span>
<span class=3Dspelle>лікарського</span> <span class=3Dspelle>засобу</span> =
<span
class=3Dspelle>має</span> <span class=3Dspelle>важливе</span> <span class=
=3Dspelle>значення</span>.
<span class=3Dspelle>Це</span> <span class=3Dspelle>дає</span> <span class=
=3Dspelle>змогу</span>
<span class=3Dspelle>проводити</span> <span class=3Dspelle>моніторинг</span=
> <span
class=3Dspelle>співвідношення</span> <span class=3Dspelle>користь</span>/<s=
pan
class=3Dspelle>ризик</span> при <span class=3Dspelle>застосуванні</span> <s=
pan
class=3Dspelle>цього</span> <span class=3Dspelle>лікарського</span> <span
class=3Dspelle>засобу</span>. <span class=3Dspelle>Медичним</span> та <span
class=3Dspelle>фармацевтичним</span> <span class=3Dspelle>працівникам</span=
>, а <span
class=3Dspelle>також</span> <span class=3Dspelle>пацієнтам</span> <span
class=3Dspelle>або</span> <span class=3Dspelle>їхнім</span> <span class=3Ds=
pelle>законним</span>
<span class=3Dspelle>представникам</span> <span class=3Dspelle>слід</span> =
<span
class=3Dspelle>повідомляти</span> про <span class=3Dspelle>усі</span> <span
class=3Dspelle>випадки</span> <span class=3Dspelle>підозрюваних</span> <span
class=3Dspelle>побічних</span> <span class=3Dspelle>реакцій</span> та <span
class=3Dspelle>відсутності</span> <span class=3Dspelle>ефективності</span> =
<span
class=3Dspelle>лікарського</span> <span class=3Dspelle>засобу</span> через =
<span
class=3Dspelle>Автоматизовану</span> <span class=3Dspelle>інформаційну</spa=
n>
систему з <span class=3Dspelle>фармаконагляду</span> за <span class=3Dspell=
e>посиланням</span>:
https://<span class=3Dspelle>aisf</span>.<span class=3Dspelle>dec</span>.<s=
pan
class=3Dspelle>gov</span>.<span class=3Dspelle>ua</span>/.<b style=3D'mso-b=
idi-font-weight:
normal'><span style=3D'color:#C00000'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-bidi-font-size:
12.0pt;color:black'>Термін придатності.</span></i></b><b style=3D'mso-bidi-=
font-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'> </=
span></b><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>2 роки.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'>Не застосовувати після закінчення терміну придатності,
зазначеного на упаковці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt'>Умови зберігання.</span></b><span lang=
=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-bidi-font-weight:bold'>Зберігати при температурі не вище </span>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>25 °С.</span><b><=
span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;mso-fareast-font-family:"Times New Roman";mso-fareast-language:RU'>З=
берігати
у недоступному для дітей місці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:#C00000'><o:p>&nbsp;</o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Упа=
ковка.</span></b><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'><o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'>По 40 г в тубах; по 1 тубі у пачці з картону. <b><o:p><=
/o:p></b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;color:#C00000'><o:p>&nbsp;</o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:black'>Кат=
егорія
відпуску.</span></b><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;colo=
r:black'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:black'>Без рецепта. <b style=3D'mso-bidi-font-weight:normal'><=
span
style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;color:#C00000;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>Виробник. <o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt'>АТ «Лубнифарм».<b style=3D'mso-bidi-font-weight:normal'><o:p></o:p>=
</b></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt;color:#C00000'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt'>Місцезнаходження виробника та адреса мі=
сця
провадження його діяльності.</span></b><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-bidi-font-size:
12.0pt'>Україна, 37500, Полтавська обл., м. Лубни,<span
style=3D'mso-spacerun:yes'>  </span><span style=3D'color:black'>вул</span>.
Барвінкова, 16. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;page-break-after:avoid;tex=
t-autospace:
ideograph-numeric'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;mso-fareast-font-family:"Times New Roman=
";
color:#C00000;mso-fareast-language:UK'><o:p>&nbsp;</o:p></span></b></p>

</div>

</body>

</html>

------=_NextPart_01D8F861.F1A72990
Content-Location: file:///C:/680CD4E2/UA197350101_83EB.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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------=_NextPart_01D8F861.F1A72990
Content-Location: file:///C:/680CD4E2/UA197350101_83EB.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D8F861.F1A72990
Content-Location: file:///C:/680CD4E2/UA197350101_83EB.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D8F861.F1A72990
Content-Location: file:///C:/680CD4E2/UA197350101_83EB.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA197350101_83EB.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D8F861.F1A72990--
